CJC-1295 is a synthetic peptide which acts as a growth hormone-releasing hormone analogue and affects GHRH receptors
Yet the consequences are unknown Bioavailability: there are four specific metabolic steps necessary to convert cyanocobalamin into one of the coenzyme forms, which is a clear metabolic disadvantage (3) Utilisation problems: certain hereditary diseases, as well as metabolic disorders, prevent the conversion of cyanocoalamin into the active B12 forms (4) Steals methyl groups: cyanocobalamin requires a methyl group to convert into methylcobalamin, which it takes from the important amino acid S-adenosylmethionine (SAM)
These therapies may not be appropriate for individuals who are pregnant or breastfeeding, have certain chronic medical conditions, active cancer, or known allergies to components of the injections
This pattern makes sense when you understand the mechanism
Tissue tolerability: For research applications involving biological systems, the concentration must not cause significant irritation at the volumes typically used
Die vorlufigen Ergebnisse, die 2023 auf einem Gastroenterologie-Kongress vorgestellt wurden, deuteten auf eine Verbesserung der Krankheitsaktivittswerte hin